Prior to this study, a diabetic mouse model fed with Enzogenol® was reported to improve diabetes-related biomarkers with a reduction in HbA1c, insulin, and glucagon levels, and an elevation of hepatic AMP-activated protein kinase (AMPK) activity [46]. This evidence concerns the gene INS and diabetes mellitus.